Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-16 of 16
Keywords: Relapse
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Ni Bai, Wasithep Limvorapitak, Robert Henderson, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Kevin Hay, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Maryse Power, Judith Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan Stubbins, Heather Sutherland, Cynthia Toze, Jennifer White
Journal:
Acta Haematologica
Acta Haematol 1–11.
Published Online: 28 August 2024
...; Jennifer White Introduction: Antithymocyte globulin (ATG) has been demonstrated to reduce the incidence of graft-versus-host disease (GVHD); however, it remains controversial whether these gains are offset by an increase in relapse. Methods: We conducted a retrospective historical control study consisting...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol 1–10.
Published Online: 17 July 2024
...Qinglin Hu; Yuan Yang; Chen Yang; Miao Chen; Bing Han Introduction: Aplastic anemia (AA) is characterized by bone marrow failure and cytopenia. Eltrombopag (ELT) is effective and safe for treating refractory/relapsed AA; however, reports on the long-term outcomes of transfusion-dependent non-severe...
Journal Articles
Patrice E. Nasnas, Elias J. Jabbour, Koji Sasaki, Ghayas C. Issa, Lucia Masarova, Nicholas J. Short, Fadi G. Haddad
Journal:
Acta Haematologica
Acta Haematol 1–6.
Published Online: 04 April 2024
...). Although uncommon, some patients may still experience molecular or hematologic relapse after treatment discontinuation, even after a prolonged duration of remission. Case Presentation: In this case series, we report the outcome of 3 patients with CML-CP who were treated with tyrosine kinase inhibitors...
Journal Articles
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W. Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Journal:
Acta Haematologica
Acta Haematol (2024) 147 (4): 435–446.
Published Online: 16 January 2024
... since the last intense treatment. Its goal was to quantify health-related complications during follow-up and assess their impact on the patients’ lives. Results: A total of 20.4% of the responding survivors reported a disease relapse, most often in indolent lymphomas. Second primary malignancies...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2024) 147 (4): 489–492.
Published Online: 23 November 2023
... and allogeneic hematopoietic cell transplantation (HCT) is often curative, it remains unknown whether any effective therapies exist for disease relapse/progression after HCT. Case Presentation: Here we present a case of a 29-year-old male with primary HLH who failed HLH-94 protocol and subsequently underwent...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2024) 147 (3): 352–359.
Published Online: 26 September 2023
...Soyoung Bae; Seungwon Sa; Silvia Park; Byung-Sik Cho; Hee-Je Kim The recently approved BCL2 inhibitor venetoclax (VEN) has achieved promising outcomes in new and relapsed/refractory (R/R) acute myeloid leukemia (AML). Although its use is not well established in R/R AML with extramedullary disease...
Journal Articles
Shun-Ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Yosuke Okada, Yu Akahoshi, Masaharu Tamaki, Machiko Kusuda, Kazuaki Kameda, Hidenori Wada, Miki Sato, Aki Tanihara, Hideki Nakasone, Shinichi Kako, Yoshinobu Kanda
Journal:
Acta Haematologica
Acta Haematol (2022) 145 (4): 404–411.
Published Online: 19 January 2022
...; Shinichi Kako; Yoshinobu Kanda ycanda-tky@umin.ac.jp Acute myeloid leukemia Relapse Neutropenia Cytarabine D-index © 2022 S. Karger AG, Basel 2022 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2020) 143 (6): 559–566.
Published Online: 01 July 2020
...Yang Liu; Lei Wen; Huan Chen; Yao Chen; Wenbing Duan; Ying Kang; Ling Ma; Xiaojun Huang; Jin Lu Background: Serum lactate dehydrogenase (LDH) is an adverse prognostic factor for newly diagnosed multiple myeloma (MM). However, the role of LDH in the prognosis of MM patients with relapse has not yet...
Journal Articles
Amanda L. Olson, Rima M. Saliba, Betul Oran, Julianne Chen, Amin Alousi, Sairah Ahmed, Qaiser Bashir, Stefan O. Ciurea, Chitra Hosing, Jin Seon Im, Partow Kebriaei, Issa F. Khouri, Rohtesh Mehta, Yago Nieto, Simrit Parmar, Katy Rezvani, Nina Shah, Elizabeth Shpall, Samer A. Srour, Muzaffar Qazilbash, Borje S. Andersson, Richard Champlin, Uday R. Popat
Journal:
Acta Haematologica
Acta Haematol (2021) 144 (1): 74–81.
Published Online: 30 June 2020
..., SWOG cytogenetic risk group, bone marrow (BM) and peripheral blood (PB) blast percentage, regimen intensity, and type of AML. At a median of 26 months after transplantation, OS, progression-free survival (PFS), non-relapse mortality, and relapse rates were 26, 24, 23, and 48%, respectively...
Journal Articles
Sanford Kempin, Zhuoxin Sun, Neil E. Kay, Elisabeth M. Paietta, Joseph J. Mazza, Rhett P. Ketterling, Olga Frankfurt, David F. Claxton, Joel N. Saltzman, Gordan Srkalovic, Natalie S. Callander, Gerald Gross, Martin S. Tallman
Journal:
Acta Haematologica
Acta Haematol (2019) 142 (4): 224–232.
Published Online: 12 November 2019
...Sanford Kempin; Zhuoxin Sun; Neil E. Kay; Elisabeth M. Paietta; Joseph J. Mazza; Rhett P. Ketterling; Olga Frankfurt; David F. Claxton; Joel N. Saltzman; Gordan Srkalovic; Natalie S. Callander; Gerald Gross; Martin S. Tallman Patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2014) 133 (1): 1–5.
Published Online: 21 June 2014
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute myeloid leukemia Trisomy 13 KIT mutation Relapse Acute myeloid leukemia (AML) is a group...
Journal Articles
Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma
Moritz Stuplich, Karin Mayer, Young Kim, Sharmilan Thanendrarajan, Matthias Simon, Niklas Schäfer, Martin Glas, Ingo G.H. Schmidt-Wolf, Ulrich Herrlinger
Journal:
Acta Haematologica
Acta Haematol (2012) 127 (2): 93–95.
Published Online: 10 December 2011
.... Brain Central nervous system Chronic lymphocytic leukemia Non-Hodgkin’s lymphoma Relapse Richter transformation Richter syndrome (RS) is defined as the development of a high-grade non-Hodgkin’s lymphoma (NHL) from a previously low-grade NHL including chronic lymphocytic leukemia (CLL...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (1978) 59 (4): 205–214.
Published Online: 03 March 2009
... cells occurred, a further cycle with a scarcely myelotoxic drug, L-asparaginase, was administered: a 10/13 (76.9%) remission of the disease was then achieved. This therapeutic trial was well accepted and could be more extensively used in the patients in relapse. A remission lasting between 4 and 28...
Journal Articles
P.H.G. Hogeman, A.J.P. Veerman, D.R. Huismans, C. Van Zantwijk, P.D. Bezemer, I.H. Stamhuis, F.C. De Waal
Journal:
Acta Haematologica
Acta Haematol (1984) 72 (3): 181–189.
Published Online: 25 February 2009
...P.H.G. Hogeman; A.J.P. Veerman; D.R. Huismans; C. Van Zantwijk; P.D. Bezemer; I.H. Stamhuis; F.C. De Waal In 53 children with acute lymphoblastic leukaemia (ALL), initial handmirror cell (HMC) count among lymphoblasts was studied in relation to the occurrence of a relapse in the central nervous...
Journal Articles
Masafumi Taniwaki, Hitoshi Nakagawa, Shinji Tanaka, Hikari Nishigaki, Shigeo Horiike, Kazuhiro Nishida, Shoichiro Tsuda, Shinichi Misawa, Johji Inazawa, Tatsuo Abe
Journal:
Acta Haematologica
Acta Haematol (1990) 83 (3): 159–162.
Published Online: 20 February 2009
..., instructions or products referred to in the content or advertisements. Cyclophosphamide Cytotoxic drugs Long arm deletion of chromosome 7 Relapse 8;21 translocation Unrelated clone Acta Haematol 1990;83:159-162 © 1990 S. Karger AG. Basel 0001-5792/90/0833-0159 S 2.75/0 Long Arm Deletion...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2000) 103 (1): 55–62.
Published Online: 13 March 2000
...Romaine Viollier; André Tichelli In a previous study, we evaluated efficacy of repeated antilymphocyte globulin (ALG) treatment for patients with severe aplastic anemia not responding to an initial ALG treatment or relapsing after initial response to ALG. We now searched in the same cohort...